title: Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases.
abstract: Repurposing has the objective of targeting existing drugs and failed, abandoned, or yet-to-be-pursued clinical candidates to new disease areas. The open-source model permits for the sharing of data, resources, compounds, clinical molecules, small libraries, and screening platforms to cost-effectively advance old drugs and/or candidates into clinical re-development. Clearly, at the core of drug-repurposing activities is collaboration, in many cases progressing beyond the open sharing of resources, technology, and intellectual property, to the sharing of facilities and joint program development to foster drug-repurposing human-capacity development. A variety of initiatives under way for drug repurposing, including those targeting rare and neglected diseases, are discussed in this review and provide insight into the stakeholders engaged in drug-repurposing discovery, the models of collaboration used, the intellectual property-management policies crafted, and human capacity developed. In the case of neglected tropical diseases, it is suggested that the development of human capital be a central aspect of drug-repurposing programs. Open-source models can support human-capital development through collaborative data generation, open compound access, open and collaborative screening, preclinical and possibly clinical studies. Given the urgency of drug development for neglected tropical diseases, the review suggests elements from current repurposing programs be extended to the neglected tropical diseases arena.
authors: Department of Management Sciences, University of Waterloo, Waterloo, ON, Canada. amallara@uwaterloo.ca
authors: Minna
authors: M
authors: Allarakhia
mesh_terms: D003299:Cooperative Behavior; D055808:Drug Discovery; D017753:Ecosystem; D006801:Humans; D058069:Neglected Diseases / Q000188:drug therapy*; D017149:Private Sector; D017150:Public Sector; D014330:Tropical Medicine
keywords: human-capacity development; models of collaboration; neglected tropical diseases; open source; rare diseases; repurposing
references: Nat Rev Drug Discov. 2004 Aug;3(8):673-83
references: 15286734
references: Afr J Med Med Sci. 2001;30 Suppl:52-4
references: 14513940
references: PLoS One. 2013 Apr 04;8(4):e60618
references: 23593264
references: PLoS Comput Biol. 2009 Jul;5(7):e1000423
references: 19578428
references: Health Policy. 2010 May;95(2-3):216-28
references: 20036435
references: Drug Discov Today. 2011 Apr;16(7-8):298-310
references: 21376136
references: J Postgrad Med. 2011 Apr-Jun;57(2):153-60
references: 21654146
references: Mt Sinai J Med. 2007 Apr;74(1):27-32
references: 17516560
references: Bioinformatics. 2008 Jun 1;24(11):1413-5
references: 18417489
references: Brief Bioinform. 2011 Jul;12(4):346-56
references: 21504985
references: Nucleic Acids Res. 2011 Jan;39(Database issue):D1060-6
references: 21071407
references: Drug Discov Today Ther Strateg. 2011 Winter;8(3-4):61-69
references: 22368688
references: Brief Bioinform. 2011 Jul;12(4):341-5
references: 21357612
references: Nat Chem Biol. 2006 Aug;2(8):415-6
references: 16816845
references: Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3424-9
references: 20142509
references: Future Med Chem. 2011 Aug;3(10):1279-88
references: 21859302
references: Br J Pharmacol. 2010 May;160(2):204-16
references: 20423335
references: Cancer Res. 2012 Mar 1;72(5):1055-8
references: 22246671
references: Antimicrob Agents Chemother. 2013 Feb;57(2):1040-6
references: 23165468
references: Expert Opin Drug Discov. 2010 Aug;5(8):709-14
references: 22827795
references: Nat Rev Drug Discov. 2010 Dec;9(12):921-9
references: 21060315
references: Nature. 2002 May 2;417(6884):74-8
references: 11986668
references: Sci Transl Med. 2011 Apr 27;3(80):80ps16
references: 21525397
references: Clin Pharmacol Ther. 2012 Aug;92(2):193-202
references: 22760003
references: Int J Parasitol Drugs Drug Resist. 2012 Jan 28;2:11-9
references: 24533267
references: Nucleic Acids Res. 2008 Jan;36(Database issue):D919-22
references: 17942422
references: Trans R Soc Trop Med Hyg. 2006 Dec;100 Suppl 1:S26-33
references: 16730038
references: J Antimicrob Chemother. 2007 Sep;60(3):526-34
references: 17584801
references: Nat Biotechnol. 2012 Jul 10;30(7):571-2
references: 22781662
references: Drug Discov Today Ther Strateg. 2011 Winter;8(3-4):77-83
references: 22768020
references: Future Med Chem. 2011 Aug;3(10):1307-15
references: 21859304
references: Expert Opin Drug Discov. 2012 Aug;7(8):643-57
references: 22657529
references: Tuberculosis (Edinb). 2011 Sep;91(5):479-86
references: 21782516
references: Orphanet J Rare Dis. 2008 Dec 16;3:33
references: 19087348
references: Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41
references: 21059682
references: Mol Biosyst. 2013 Jun;9(6):1268-81
references: 23493874
references: BMC Bioinformatics. 2008 Feb 19;9:104
references: 18282303
references: Pharmacoeconomics. 1995 Nov;8(5):374-84
references: 10160072